Evidence map›Paper›PMID 10212294›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1999

Tonic dopamine inhibition of L-type Ca2+ channel activity reduces alpha1D Ca2+ channel gene expression.

D M Fass, K Takimoto, R E Mains, E S Levitan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Disease-modifying, multidimensional efficacy of putaminal CaMolecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  7. Article
  8. Review
  9. Article
  10. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

D M FassDepartment of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.
K Takimoto
R E Mains
E S Levitan
University of Pittsburgh · USJohns Hopkins Medicine · US

Funding

UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.P50DA000266 · NIDA · JOHNS HOPKINS UNIVERSITY · PI WORLEY, PAUL F · 1985 to 2017
$45.2M
Dense-Core Vesicle Circulation, Capture and Synaptic Neuropeptide ReleaseR01NS032385 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EDWIN S LEVITAN · 1995 to 2026
$13.0M
REGULATION OF CARDIAC ION CHANNEL EXPRESSIONR01HL055312 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEVITAN, EDWIN S · 1996 to 2004
$1.5M
NHLBI NIH HHS HL55312NHLBI NIH HHS R01 HL055312NIDA NIH HHS DA-00266NIDA NIH HHS P50 DA000266NINDS NIH HHS NS32385NINDS NIH HHS R01 NS032385
6 · The paper itself

Abstract

Hormones and neurotransmitters have both short-term and long-term modulatory effects on the activity of voltage-gated Ca2+ channels. Although much is known about the signal transduction underlying short-term modulation, there is far less information on mechanisms that produce long-term effects. Here, the molecular basis of long-lasting suppression of Ca2+ channel current in pituitary melanotropes by chronic dopamine exposure is examined. Experiments involving in vivo and in vitro treatments with the dopaminergic drugs haloperidol, bromocriptine, and quinpirole show that D2 receptors persistently decrease alpha1D L-type Ca2+ channel mRNA and L-type Ca2+ channel current without altering channel gating properties. In contrast, another L-channel (alpha1C) mRNA and P/Q-channel (alpha1A) mRNA are unaffected. The downregulation of alpha1D mRNA does not require decreases in cAMP levels or P/Q-channel activity. However, it is mimicked and occluded by inhibition of L-type channels. Thus, interruption of the positive feedback between L-type Ca2+ channel activity and alpha1D gene expression can account for the long-lasting regulation of L-current produced by chronic activation of D2 dopamine receptors.

Indexed as

Gene Expression RegulationAnimalsBromocriptineCalcium ChannelsCalcium Channels, L-TypeCells, CulturedDopamineDopamine AgonistsDopamine AntagonistsFemaleHaloperidolPatch-Clamp TechniquesPituitary Gland, PosteriorQuinpiroleRatsRats, Sprague-DawleyBromocriptineCalcium ChannelsCalcium Channels, L-TypeDopamineDopamine AgonistsDopamine AntagonistsHaloperidolQuinpiroleReceptors, Dopamine D2RNA, Messenger

Identifiers

PMID10212294
PMCPMC6782228
OpenAlexW1520953060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.